• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W. L. GORE & ASSOCIATES, INC. GORE® EXCLUDER® AAA ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W. L. GORE & ASSOCIATES, INC. GORE® EXCLUDER® AAA ENDOPROSTHESIS; SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT Back to Search Results
Model Number RLT281412
Device Problem Fluid/Blood Leak (1250)
Event Date 12/15/2022
Event Type  Injury  
Manufacturer Narrative
(b)(4).The instructions for use (ifu) for the gore® excluder® aaa endoprosthesis states, adverse events that may occur and / or require intervention include but are not limited to: endoleak, occlusion of device or native vessel, rupture.W.L.Gore & associates, inc.(gore) is submitting this report to comply with 21 c.F.R.Part 803, the medical device reporting regulation.This report is based upon information obtained by gore, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Blank fields present on this report include required fields and fields determined to be not applicable.Blank required fields indicate that the information was not provided, was deemed unavailable or was not applicable.This report does not constitute an admission or a conclusion by fda, gore, or its associates that the device, gore or its associates caused or contributed to the event described in the report.In particular, this report does not constitute a legal admission by anyone that the product described in this report has any defects or has malfunctioned, as defined from a legal standpoint.These words are included in the report and are fixed items for selection created by the fda, to categorize the type of event solely for the purpose of reporting pursuant to part 803.This statement should be included with any information or report disclosed to the public under the freedom of information act.
 
Event Description
On (b)(6) 2015, this patient underwent endovascular treatment of an abdominal aortic aneurysm and was implanted with gore® excluder® aaa endoprosthesis.Follow-up ultrasound on (b)(6) 2015 reported the maximum diameter of aortic aneurysm/lesion (mm) measured 52mm.Follow-up ultrasound on (b)(6) 2015 reported the maximum diameter of aortic aneurysm/lesion (mm) measured 85mm and a new endoleak (type not identified).On (b)(6) 2023, a reintervention is planned wherein possible coiling of an accessory vessel related to the endoleak may be performed.
 
Event Description
On (b)(6) 2023 follow-up computed tomography angiography (cta) measured the sac at 8.7 x 8.3 and reported ¿a small type-2 endoleak¿.A gore representative (at our request) reviewed films extensively, and stated that he could not discern any leak.The patient is asymptomatic and 93 year old and has expressed some doubt that he would want to have any further reinterventions, but is scheduled for reintervention on (b)(6) 2023.
 
Event Description
On (b)(6) 2023, the patient underwent endovascular re-intervention wherein coil embolization of the filling lumbar branches to the aortic sac was performed.Completion arteriogram of the hypogastric artery showed no further communication of the lumbar branches to the a aneruysm sac.The patient tolerated the procedure.
 
Manufacturer Narrative
B4: additional information.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® EXCLUDER® AAA ENDOPROSTHESIS
Type of Device
SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT
Manufacturer (Section D)
W. L. GORE & ASSOCIATES, INC.
1505 n. fourth street
flagstaff AZ 86004
Manufacturer (Section G)
MEDICAL WOODY MOUNTAIN B/P
3750 w. kiltie lane
flagstaff AZ 86005
Manufacturer Contact
laura crawford
1505 n. fourth street
flagstaff, AZ 86004
9285263030
MDR Report Key16080870
MDR Text Key306495759
Report Number2017233-2022-03612
Device Sequence Number1
Product Code MIH
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P020004
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Study
Reporter Occupation Physician
Type of Report Initial,Followup,Followup,Followup
Report Date 03/31/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date07/16/2018
Device Model NumberRLT281412
Device Catalogue NumberRLT281412
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 12/16/2022
Initial Date FDA Received12/30/2022
Supplement Dates Manufacturer Received12/16/2022
12/16/2022
12/16/2022
Supplement Dates FDA Received01/30/2023
03/03/2023
03/31/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured07/17/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Hospitalization; Other;
Patient Age86 YR
Patient SexMale
Patient Weight88 KG
-
-